Literature DB >> 17279686

Preparation of protein-silicate hybrids from polyamine intercalation of layered montmorillonite.

Jiang-Jen Lin1, Jiun-Chiou Wei, Tzong-Yuan Juang, Wei-Cheng Tsai.   

Abstract

Hybrids of the model BSA protein and layered silicate clay with d spacing of approximately 62 A were prepared from either direct or stepwise intercalation. The pristine montmorilloinite (Na+-MMT) was first modified by poly(oxyalkylene)-amine salts (POP- and POE-amine) of 2000 g/mol Mw to a gallery-expanded silicate (d spacing=53 and 18 A, respectively), which became accessible for BSA protein embedding. Subsequent BSA substitution allowed the embedding of the protein into the layered clay galleries in an uncompressed conformation. The stepwise process of embedding large molecules into the silicate gallery provides a new method for synthesizing biomaterial/clay hybrids potentially useful in drug delivery or biomedical design.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17279686     DOI: 10.1021/la062013h

Source DB:  PubMed          Journal:  Langmuir        ISSN: 0743-7463            Impact factor:   3.882


  3 in total

1.  Mitigation of colitis with NovaSil clay therapy.

Authors:  Katherine E Zychowski; Sarah E Elmore; Kristal A Rychlik; Hoai J Ly; Felipe Pierezan; Anitha Isaiah; Jan S Suchodolski; Aline Rodrigues Hoffmann; Amelia A Romoser; Timothy D Phillips
Journal:  Dig Dis Sci       Date:  2014-09-21       Impact factor: 3.199

2.  Effective intercalation of zein into Na-montmorillonite: role of the protein components and use of the developed biointerfaces.

Authors:  Ana C S Alcântara; Margarita Darder; Pilar Aranda; Eduardo Ruiz-Hitzky
Journal:  Beilstein J Nanotechnol       Date:  2016-11-18       Impact factor: 3.649

3.  Montmorillonite Poly-L-Lactide Microcomposites of Procainamide for controlled drug delivery: In vitro and In vivo evaluation.

Authors:  B D Kevadiya; T K Patel; Parvati B Patel; Shalini Rajkumar; C B Tripathi; H C Bajaj
Journal:  Indian J Pharm Sci       Date:  2013-11       Impact factor: 0.975

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.